Your browser doesn't support javascript.
loading
Antibody responses of the first wave of survivors infected with SARS-CoV-2 1 year ago.
He, Lu; Zeng, Cheng; Zeng, Yuyang; Xu, Wanzhou; Li, Ying; Xie, Xiaojie; Xu, Wei; Xia, Hongmiao; Tang, Fengjuan; Tang, Shiqi; Xu, Lijuan; Chen, Changzheng.
  • He L; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • Zeng C; Department of Orthopedics, Affiliated Hospital of Hebei University, Baoding, China.
  • Zeng Y; Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Xu W; Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
  • Li Y; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • Xie X; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • Xu W; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • Xia H; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • Tang F; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • Tang S; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • Xu L; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
  • Chen C; Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
J Med Virol ; 94(5): 1770-1772, 2022 05.
Article en En | MEDLINE | ID: mdl-34952979

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Anticuerpos Antivirales / Formación de Anticuerpos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Anticuerpos Antivirales / Formación de Anticuerpos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article